What is Generate Biomedicines, Inc. 's book value per share?

Generate Biomedicines, Inc. (GENB) reported book value per share of $7.94 in Q1 2026.

What does book value per share mean?

Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.

Generate Biomedicines, Inc. GENB Book value per share

Book value per share at other companies

RepligenRGEN

$37.16+5.8%

Piper SandlerPIPR

$18.84+10.4%

NNN REITNNN

$23.20-0.4%

MYR GroupMYRG

$41.99+15.6%

Silgan HoldingsSLGN

$21.92+12.9%

FTI ConsultingFCN

$54.79-9.5%

Other financials

Income statement

See full

Revenue$7.2M-18.1%

Operating income-$64.1M-33.1%

Net income-$61.4M-47.4%

EPS (diluted)-$1.07+34.0%

Balance sheet

See full

Cash & equivalents$160.6M-27.2%

Total debt$65.6M—

Total equity$514.8M+209%

Total assets$625.7M—

Cash flow

See full

Operating cash flow-$80.4M-51.2%

CapEx$3.8M+403%

Free cash flow-$84.2M-56.1%

Valuation

See full

Market cap$1.86B—

Enterprise value$1.76B—

Returns & leverage

See full

Debt / equity0.1×—

Current ratio9.2×—

Where this comes from

Calculated from Generate Biomedicines, Inc. ’s reported figures.

total stockholders equity/weighted shares diluted=$7.94

Based on the most recent quarter.

The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Generate Biomedicines, Inc. 's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Generate Biomedicines, Inc. 's book value per share?: Generate Biomedicines, Inc. (GENB) reported book value per share of $7.94 in Q1 2026.
What does book value per share mean?: Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.